Rosa RG, Falavigna M, Manfio JL, de Araujo CLP, et al. BNT162b2 mRNA COVID-19 against symptomatic Omicron infection following a mass vaccination campaign in southern Brazil: A prospective test-negative design study. Vaccine 2023 Jul 26:S0264-410X(23)00869-1. doi: 10.1016/j.vaccine.2023.
PMID: 37507274